C-Trelin OD Tab(5mg Taltirelin Hydrate) ( DrugBank: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
18	脊髄小脳変性症（多系統萎縮症を除く。）	1

18. 脊髄小脳変性症（多系統萎縮症を除く。）

臨床試験数 : 71 / 薬物数 : 99 - (DrugBank : 30) / 標的遺伝子数 : 45 - 標的パスウェイ数 : 65

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04107740 (ClinicalTrials.gov)	February 20, 2019	10/9/2019	C-Trelin Orally Disintegrated(OD) Tablet 5mg in Ataxia Due to Spinocerebellar Degeneration	Multicenter, Randomized, Double-blind, Placebo-controlled, Phase IV Clinical Trial to Evaluate and C ...	Spinocerebellar Degeneration	Drug: C-Trelin OD Tab(5mg Taltirelin Hydrate);Drug: Placebo	MediForum Pharm	NULL	Recruiting	20 Years	N/A	All	166	Phase 4	Korea, Republic of

First Previous1Next Last